- Filed
- Dec 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 198.38M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 195M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 183.59M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 142.99M sh |
| Capex | Q3 2026 · Oct 31, 2025 | $11.09M |
| Capex | Q3 2026 · Oct 31, 2024 | $11.3M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | $189.86M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | −$35.37M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $307.1M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $186.33M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | −$524.41M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | −$564.34M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | −$553.73M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | −$521.09M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | −$499.29M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | −$1.42B |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $1.16B |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $950.18M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $3.07B |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $1.98B |
| Current Assets | Q3 2026 · Oct 31, 2025 | $2.07B |
| Current Assets | Q3 2026 · Jan 31, 2025 | $1.08B |
| Total Assets | Q3 2026 · Oct 31, 2025 | $2.55B |
| Total Assets | Q3 2026 · Jan 31, 2025 | $1.42B |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$0.32 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$1.34 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | −$0.71 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | −$7.27 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$0.32 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$1.34 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | −$0.71 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | −$7.27 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $66.78M |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $192.73M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $65.86M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $281.25M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $97.58M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $271.5M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $80.05M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $451.66M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$63.83M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$261.86M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$130.91M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$1.04B |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$75.48M |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$263.04M |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$124.79M |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$1.02B |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $282.03M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $746.33M |
| Gross Profit | Q3 2026 · Oct 31, 2024 | $180.03M |
| Gross Profit | Q3 2026 · Oct 31, 2024 | $421.15M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $68.14M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $192.18M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2024 | $56.15M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2024 | $207.29M |
| Revenue | Q3 2026 · Oct 31, 2025 | $350.17M |
| Revenue | Q3 2026 · Oct 31, 2025 | $938.51M |
| Revenue | Q3 2026 · Oct 31, 2024 | $236.18M |
| Revenue | Q3 2026 · Oct 31, 2024 | $628.44M |